<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01258829</url>
  </required_header>
  <id_info>
    <org_study_id>10/H0803/86</org_study_id>
    <nct_id>NCT01258829</nct_id>
  </id_info>
  <brief_title>British Randomised Controlled Trial of Atrioventricular (AV) and Interventricular (VV) Optimisation (BRAVO)</brief_title>
  <acronym>BRAVO</acronym>
  <official_title>British Randomised Controlled Trial of AV and VV Optimisation (BRAVO): Randomised Clinical Trial of the Effects of Non-invasive Haemodynamic Optimisation of Cardiac Resynchronisation Devices on Exercise Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients who have cardiac resynchronisation therapy (a type of pacemaker) implanted for
      heart failure do not have the settings of their device optimised. The most widely available
      method for optimisation uses flow measured using cardiac ultrasound (echocardiography) to
      determine the optimal settings. However, this is not frequently performed because it is time
      consuming and requires two skilled operators. In this study the investigators will test a new
      non-invasive method for optimisation, which utilises pressure measurements (non-invasive
      blood pressure measured from the finger).

      Is optimising AV and VV delay using non-invasive haemodynamics at least equivalent, in terms
      of exercise capacity, to conventional echo optimisation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Is optimising AV and VV delay using non-invasive haemodynamics at least equivalent, in terms of exercise capacity, to conventional echo optimisation</measure>
    <time_frame>6 months following the last follow-up of the last patient</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine whether pressure optimisation is at least equivalent to echo optimisation of flow: in terms resulting size of the heart in terms of quality of life scores in terms of blood marker of heart failure severity</measure>
    <time_frame>6 months following the last follow-up of the last patient</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">403</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Non-invasive haemodynamic optimisation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optimization of pressure production by the heart, as measured by systolic blood pressure in the systemic circulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ECHO optimisation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Optimization of AV/VV delay using the guideline recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-invasive haemodynamic optimisation</intervention_name>
    <description>Comparing the method of non-invasive haemodynamic</description>
    <arm_group_label>Non-invasive haemodynamic optimisation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECHO optimisation</intervention_name>
    <description>Standard ECHO optimisation method</description>
    <arm_group_label>ECHO optimisation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic heart failure due to systolic dysfunction

          -  Biventricular pacemaker implanted

          -  Give written informed consent

        Exclusion Criteria:

          -  Lung disease or any condition that would preclude them from walking on a treadmill
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Darrel Francis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ICCH, Imperial College London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2010</study_first_submitted>
  <study_first_submitted_qc>December 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2010</study_first_posted>
  <last_update_submitted>June 29, 2015</last_update_submitted>
  <last_update_submitted_qc>June 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure Cardiac Resynchronisation Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

